SS
UTHR icon

SBI Securities’s United Therapeutics UTHR Stock Holding History

SBI Securities’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Buy
410
+1
+0.2% +$563 0.01% 630
2026
Q1 		$243K Sell
409
-15
-4% -$7.47K 0.01% 574
2025
Q4 		$207K Sell
424
-33
-7% -$15.4K 0.01% 619
2025
Q3 		$192K Buy
457
+320
+234% +$108K ﹤0.01% 642
2025
Q2 		$39.4K Buy
137
+5
+4% +$1.49K ﹤0.01% 1138
2025
Q1 		$40.7K Sell
132
-240
-65% -$82.2K ﹤0.01% 1057
2024
Q4 		$131K Buy
+372
New +$137K ﹤0.01% 675

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

SBI Securities's UTHR Position: Q2 2026 in Review

SBI Securities increased its United Therapeutics (UTHR) stake by 0.24% in Q2 2026, buying an estimated $563 and bringing the position to 410 shares worth $222K. The position accounts for 0.01% of the portfolio, ranked #630.

SBI Securities first reported a position in UTHR in Q4 2024 and has held it in 7 quarters since. The position peaked at $243K in Q1 2026. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • SBI Securities held 410 shares of United Therapeutics worth $222K as of Q2 2026.
  • SBI Securities bought 1 United Therapeutics share in Q2 2026, an estimated $563.
  • United Therapeutics made up 0.01% of SBI Securities's portfolio in Q2 2026, its #630 holding.
  • SBI Securities first reported a position in United Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's United Therapeutics position peaked at $243K in Q1 2026.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.